DalsnaFinance › IPOs › 4d Molecular Therapeutics Inc › IPO

4D Molecular Therapeutics, Inc. IPO

Completed

4D Molecular Therapeutics, Inc. completed its initial public offering on NASDAQ on December 11, 2020, pricing at $23.00 a share.

Ticker	FDMT
Exchange	NASDAQ
Status	Completed
Listing date	December 11, 2020
Offering price	$23.00
Shares offered	8,400,000
Total raised	$193M

The offering

4D Molecular Therapeutics, Inc. sold 8,400,000 shares at $23.00 each on NASDAQ. Multiplied out, that is $193.2 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $193 million total recorded for the deal.

Company coverage

4D Molecular Therapeutics, Inc. — quote, profile and latest news →

Other recent IPOs

Iambic Therapeutics, Inc. · October 13, 2026
Retension Pharmaceuticals, Inc. · October 8, 2026
Frazier Life Sciences Acquisition Corp. II · October 8, 2026
TRex Bio, Inc. · October 6, 2026
Pine Tree Acquisition Corp. · October 5, 2026
Accelevation Holdings Corp. · September 30, 2026
Southport Acquisition Corp. II · September 30, 2026
ROZE AI INC. · September 28, 2026

Source: SEC EDGAR filings for 4D Molecular Therapeutics, Inc.. This page is general information, not investment advice.